Aspergillosis Drug Development: Navigating Innovation, Access, and Global Health Needs Aspergillosis refers to a spectrum of infections caused by Aspergillus species, ranging from allergic reactions to invasive and life‑threatening systemic disease. In vulnerable populations — such as immunocompromised patients, transplant recipients, or those undergoing chemotherapy — the risk is especially high, demanding more efficacious and targeted therapeutic options.
According...
Join our community to interact with posts!